Skip to main content
. 2022 Apr 25;13:834113. doi: 10.3389/fphar.2022.834113

TABLE 4.

Clinical outcome of the duration of response (DOR).

Study CAR T Median Duration of Response, months Median Follow up, months
Locke et al. (2019) axi-cel 11.1 (4.2-NE) 27.1
Ying et al. (2021) relma-cel 8.0 (6.0-NR) 8.9
Zhou et al. (2020) lab 6.8 13.7
Iacoboni et al. (2021) tisa-cel 8.9 (2.2-NE) 14.1
Abramson et al. (2020) Liso-cel 23.1 (8.6-NR) 23.0

CAR T: chimeric antigen receptor T cells; NE: not estimated; NR: not reached.